Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.
Cantini F, Niccoli L, Nannini C, Matarrese D, Natale MED, Lotti P, Aquilini D, Landini G, Cimolato B, Pietro MAD, et al. J Infect. 2020 Oct; 81(4):647-679. Epub 2020 Jun 24.